Investing 22 May 2026 - 23 May 2026

Avidbank Stock’s Quiet Weekly Climb Leaves One Bigger Test After the Long Weekend

Avidbank Stock’s Quiet Weekly Climb Leaves One Bigger Test After the Long Weekend

Avidbank Holdings shares closed at $29.91 Friday, up 2.19% for the week, ahead of the Memorial Day market closure. Shareholders re-elected all 10 board nominees and ratified Crowe LLP as auditor at the May 19 annual meeting. First-quarter net income was $9.0 million, with net interest margin at 4.38%. Deposits grew, including a $38.5 million increase in brokered deposits.
May 23, 2026
All eyes on Autodesk ahead of earnings

All eyes on Autodesk ahead of earnings

Autodesk shares closed Friday at $240.99, up 0.33% for the day and 1.9% for the week. U.S. markets are closed for Memorial Day on Monday, leaving three trading days before Autodesk reports fiscal Q1 earnings after the close on May 28. The company has forecast revenue of $1.885–$1.900 billion and non-GAAP EPS of $2.82–$2.86.
May 23, 2026
Crown Crafts Stays Flat; $0.08 Dividend Keeps Eyes on June 11

Crown Crafts Stays Flat; $0.08 Dividend Keeps Eyes on June 11

Crown Crafts Inc. shares closed Friday at $2.75, flat for the week, with trading paused until Tuesday due to Memorial Day. The company’s $0.08 quarterly dividend, payable July 2, implies an 11.6% yield at current prices. Net sales fell to $20.7 million in the latest quarter, while net income rose to $1.5 million. China remains its main supplier, with tariffs and retail concentration flagged as risks.
May 23, 2026
Canadian Solar Shares Rise Ahead of Holiday, But Wall Street Stays Cautious

Canadian Solar Shares Rise Ahead of Holiday, But Wall Street Stays Cautious

Canadian Solar shares climbed 4.3% to $18.88 Friday, ending the week up about 5.6% as U.S. markets closed for Memorial Day. The company reported Q1 revenue of $1.1 billion and a narrowed net loss of $32 million, aided by a $93 million tariff refund. CEO Colin Parkin warned margins remain under pressure, with U.S. factory ramp-up and storage orders in focus for the coming weeks.
May 23, 2026
ARTW Stock Slips Before Memorial Day—Why Tuesday’s Open Could Matter for Art’s-Way Investors

ARTW Stock Slips Before Memorial Day—Why Tuesday’s Open Could Matter for Art’s-Way Investors

Art’s-Way Manufacturing shares closed at $2.61 Friday, down 1.9%, underperforming the Russell 2000’s 2.7% weekly gain ahead of the Memorial Day market closure. The company last reported Q1 sales up 29% to $6.64 million and net income of $196,442, but flagged weaker sugar beet equipment demand and rising steel costs. Order backlog rose 62.6% year-over-year to $7.29 million as of April 7.
May 23, 2026
EFSI Drops After Shareholder Meeting, Investors Look Again at Small Bank

EFSI Drops After Shareholder Meeting, Investors Look Again at Small Bank

Eagle Financial Services Inc fell 1% to $39.10 on Friday, reversing part of Thursday’s 5.9% gain as investors reviewed results from a shareholder vote. The company’s new employee stock purchase plan passed with 3.32 million votes in favor and reserves 160,000 shares. First-quarter net income dropped to $3.7 million from $4.3 million in the fourth quarter. Provision for credit losses rose to $2.0 million.
May 23, 2026
Axogen Shares Dip Ahead of Holiday as Broader Market Holds Up

Axogen Shares Dip Ahead of Holiday as Broader Market Holds Up

Axogen Inc. shares closed down 1% at $40.90 on Friday, underperforming a rising U.S. market before the Memorial Day holiday. The drop came despite no new company news and recent analyst price target hikes after strong first-quarter revenue growth. Axogen reported a net loss of $19.6 million but positive adjusted income. The FDA approved its Avance Nerve Graft in December, granting potential 12-year U.S. exclusivity.
May 23, 2026
BioAge Stock Dropped Before June Investor Call on Key Drug

BioAge Stock Dropped Before June Investor Call on Key Drug

BioAge Labs shares fell 0.8% to $16.61 Friday, trailing a stronger Nasdaq. The company set June 4 investor meetings but released no new clinical data. Investors are watching for two mid-2026 proof-of-concept trials of BGE-102, its oral NLRP3 inhibitor for cardiovascular and retinal diseases. April Phase 1 data showed at least 85% median reductions in hsCRP, with no serious adverse events.
May 22, 2026
ABTS Stock Still Trading Under $1, But Traders Are Watching This Small Bitcoin Miner

ABTS Stock Still Trading Under $1, But Traders Are Watching This Small Bitcoin Miner

Abits Group Inc. shares traded at $0.8602, up 0.93% Friday, but stayed near a 52-week low as light volume preceded the Memorial Day weekend. The bitcoin miner reported 2025 revenue of $9.13 million and a $2.87 million after-tax loss. Year-end cash fell to $83,837, while digital assets rose to $1.48 million. The stock remains below $1, raising continued Nasdaq listing concerns.
May 22, 2026
KNDI Shares Stay Below $1 as Nasdaq Deadline Looms

KNDI Shares Stay Below $1 as Nasdaq Deadline Looms

Kandi Technologies shares traded at 72 cents Friday morning in New York, remaining below Nasdaq’s $1 minimum bid requirement. The company has until Nov. 2 to regain compliance or risk delisting. Kandi reported 2025 net revenue of $87.4 million, down sharply from 2024, with most sales from off-road vehicles. Broader U.S. markets rose ahead of Memorial Day, but Kandi’s stock lagged.
May 22, 2026
1 2 3 4 5 6 32